Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2023 Jun 30;102(26):e33923.
doi: 10.1097/MD.0000000000033923.

The acceptance and hesitancy of COVID-19 vaccination among chronic obstructive pulmonary disease (COPD) patients

Affiliations

The acceptance and hesitancy of COVID-19 vaccination among chronic obstructive pulmonary disease (COPD) patients

Ting Wang et al. Medicine (Baltimore). .

Abstract

Severe acute respiratory syndrome coronavirus 2, which is responsible for the coronavirus disease 2019 (COVID-19), causes severe clinical outcomes in old individuals and patients with underlying diseases, including chronic obstructive pulmonary disease (COPD). Considering vaccination is still the most effective method to prevent COVID-19-associated death, it is imperative to evaluate COPD patients' attitudes toward the COVID-19 vaccine. This cross-sectional design study was conducted to assess vaccine acceptance and hesitancy among 212 COPD patients who attended the outpatient department from January 1, 2021, to July 31, 2022. All of the patients were not vaccinated and had undertaken lung function test at the time of our survey. Of 212 participants, 164 (77.4%) were willing to be vaccinated immediately while 48 (22.6%) were hesitant to be vaccinated. Compared with the acceptance group, patients who did not accept the vaccination instantly tended to have more comorbidities, like hypertension, coronary heart disease, recent cancers, and higher Modified British Medical Research Council score, or more frequent acute exacerbation. For the patients willing to be vaccinated, the main factors motivating them were an authorities-endorsed vaccine, free vaccination, and no obvious adverse reactions. For the hesitant group, no recommendation from the treating physician was the biggest obstacle for them to accept vaccination. Our results provide useful guidance for making intervention measures to enhance COPD patients' acceptance of a new COVID-19 vaccine. For those patients with comorbidities, treating physicians promoting messages framing the safety of vaccination is necessary to increase immunization rates.

PubMed Disclaimer

Conflict of interest statement

The authors have no conflicts of interest to disclose.

Figures

Figure 1.
Figure 1.
COVID-19 vaccination ratio at different GOLD grades of vaccine-acceptant group and vaccine-hesitant group. COVID-19 = coronavirus disease 2019, GOLD = Global Initiative for Chronic Obstructive Lung Disease.
Figure 2.
Figure 2.
COVID-19 vaccination ratio in different COPD groups (Group A, B, C, D). COPD = chronic obstructive pulmonary disease, COVID-19 = coronavirus disease 2019.

References

    1. Coronavirus Worldometer. Available at: www.worldometers.info/coronavirus/. [Access date January 09, 2022].
    1. Zhao Q, Meng M, Kumar R, et al. . The impact of COPD and smoking history on the severity of COVID-19: a systemic review and meta-analysis. J Med Virol. 2020;92:1915–21. - PMC - PubMed
    1. Hasan SS, Capstick T, Zaidi STR, et al. . Use of corticosteroids in asthma and COPD patients with or without COVID-19. Respir Med. 2020;170:106045. - PMC - PubMed
    1. Higham A, Mathioudakis A, Vestbo J, et al. . COVID-19 and COPD: a narrative review of the basic science and clinical outcomes. Eur Respir Rev. 2020;29:200199. - PMC - PubMed
    1. Alqahtani JS, Oyelade T, Aldhahir AM, et al. . Prevalence, severity and mortality associated with COPD and smoking in patients with COVID-19: a rapid systematic review and meta-analysis. PLoS One. 2020;15:e0233147. - PMC - PubMed

Substances

LinkOut - more resources